Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05650021 · ClinicalTrials.gov registry record · NA
Rectal Spacer for Prostate Cancer Radiation Image Guidance
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05650021 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT05650021, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if a radiopaque hydrogel rectal spacer, SpaceOAR Vue®, can be used in place of fiducial markers when aligning patients for radiotherapy. The investigator hypothesizes that the alignment of the patient based on the rectal spacer will be similar to the alignment of the patient with fiducial markers.
Interventions
- DEVICE SpaceOAR Vue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2025-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05650021
The ClinicalTrials.gov registry entry for NCT05650021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpaceOAR Vue is the first listed.
NCT05650021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05650021 about?
NCT05650021 is a clinical study titled "Rectal Spacer for Prostate Cancer Radiation Image Guidance". The purpose of the study is to determine if a radiopaque hydrogel rectal spacer, SpaceOAR Vue®, can be used in place of fiducial markers when aligning patients for radiotherapy. The investigator hypothesizes that the alignment of the patient based on the rectal spacer will be similar to the alignmen...
What is the current status of trial NCT05650021?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-03-08. Estimated completion is 2025-09-15.
What interventions are being tested in trial NCT05650021?
The interventions under investigation include: SpaceOAR Vue (DEVICE).
Who is sponsoring clinical trial NCT05650021?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.